The European Prospective Investigation into Cancer and Nutrition (EPIC) is a multicentre
prospective study conducted in 23 centres in 10 European countries. Here we review the …

Gastrointestinal (GI) cancers, including colorectal cancer, gastric cancer, and esophageal
cancer, are a major medical and economic burden worldwide and have the largest number …

Background Colorectal cancer screening programmes and uptake vary substantially across
Europe. We aimed to compare changes over time in colorectal cancer incidence, mortality …

The incidence of rectal cancer in the European Union is $125 000 per year, ie $35% of the
total colorectal cancer incidence, reflecting 15–25 cases/100000 population per year and is …

Colorectal cancer (CRC) is one of the most common malignancies in the United States.
Every 3 years, the American Cancer Society provides an update of CRC incidence, survival …

Cancer chemoprevention involves the use of different natural or biologic agents to inhibit or
reverse tumor growth. Epidemiological and pre-clinical data suggest that various natural …

Background Colorectal cancer (CRC) is the third most common diagnosed cancer in men
and the second in women. Dietary factors and lifestyle may contribute to the increasing CRC …

Conventional therapies for cancer treatment have posed many challenges, including toxicity,
multidrug resistance and economic expenses. In contrast, complementary alternative …

Introduction: We present the protocol of a large population-based case-control study of 5
common tumors in Spain (MCC-Spain) that evaluates environmental exposures and genetic …

Background & Aims The combined effects of healthy lifestyle factors on colorectal cancer
(CRC) risk are unclear. We aimed to develop a healthy lifestyle score, to investigate the joint …